Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose https://t.co/zeydNyfmA8
2,460 followers
323 followers
RT @Allergy_bio: Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose: Patients with Myelod…
323 followers
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose: Patients with Myelodysplastic Syndromes (MDS) and secondary Acute Myeloid Leukemia (sAML) have a very poor prognosis after failure of hypomethylating… htt
952 followers
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose. https://t.co/cGH27ue8xV